Table 1.
Healthy | No neuP | Mild neuP | Mod/sev neuP | P | |
---|---|---|---|---|---|
No. of participants, n (%) | 32 | 22 (20) | 54 (50) | 32 (30) | |
Sex female (%) | 24 (75) | 12 (55) | 37 (69) | 23 (72) | 0.426# |
Mean age (SD), yrs | 57.2 (12.4) | 59.0 (14.5) | 59.9 (13.5) | 57.2 (10.1) | 0.725* |
Mean height (SD), cm | 163.02 (29.9) | 168.3 (9.6) | 165.7 (10.4) | 168.0 (9.0) | 0.599* |
Mean weight (SD), kg | 73.8 (16.9) | 75.1 (9.8) | 73.0 (17.0) | 79.6 (16.8) | 0.307* |
Median symptom duration [IQR], mo | 40 [83] | 48 [42]† | 18 [30] | 0.006* |
P values are presented for one-way ANOVAs. # P value represents χ2 test association values.Significant overall comparisons are highlighted in bold.
Significant Bonferroni-adjusted Helmert contrasts are indicated for mild vs moderate/severe neuP groups. Contrasts between no neuP vs combined neuP groups were not significant.
ANOVA, analysis of variance; IQR, interquartile range.; neuP, neuropathic pain; SD, standard deviation